Addendum 1. Use of isotopes in bioavailability testing
Autor*in: |
Riegelman, Sidney [verfasserIn] Rowland, Malcolm [verfasserIn] Benet, Leslie Z. [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
1973 |
---|
Schlagwörter: |
---|
Übergeordnetes Werk: |
Enthalten in: Journal of Pharmacokinetics and Biopharmaceutics - Kluwer Academic Publishers-Plenum Publishers, 1973, 1(1973), 1 vom: Feb., Seite 83-87 |
---|---|
Übergeordnetes Werk: |
volume:1 ; year:1973 ; number:1 ; month:02 ; pages:83-87 |
Links: |
---|
DOI / URN: |
10.1007/BF01060029 |
---|
Katalog-ID: |
SPR014694255 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | SPR014694255 | ||
003 | DE-627 | ||
005 | 20230519072601.0 | ||
007 | cr uuu---uuuuu | ||
008 | 201006s1973 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/BF01060029 |2 doi | |
035 | |a (DE-627)SPR014694255 | ||
035 | |a (SPR)BF01060029-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Riegelman, Sidney |e verfasserin |4 aut | |
245 | 1 | 0 | |a Addendum 1. Use of isotopes in bioavailability testing |
264 | 1 | |c 1973 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
650 | 4 | |a Dosage Form |7 (dpeaa)DE-He213 | |
650 | 4 | |a Total Radioactivity |7 (dpeaa)DE-He213 | |
650 | 4 | |a Intact Drug |7 (dpeaa)DE-He213 | |
650 | 4 | |a Final Dosage Form |7 (dpeaa)DE-He213 | |
650 | 4 | |a Bioavailability Test |7 (dpeaa)DE-He213 | |
700 | 1 | |a Rowland, Malcolm |e verfasserin |4 aut | |
700 | 1 | |a Benet, Leslie Z. |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of Pharmacokinetics and Biopharmaceutics |d Kluwer Academic Publishers-Plenum Publishers, 1973 |g 1(1973), 1 vom: Feb., Seite 83-87 |w (DE-627)SPR014694166 |7 nnns |
773 | 1 | 8 | |g volume:1 |g year:1973 |g number:1 |g month:02 |g pages:83-87 |
856 | 4 | 0 | |u https://dx.doi.org/10.1007/BF01060029 |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_SPRINGER | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_40 | ||
951 | |a AR | ||
952 | |d 1 |j 1973 |e 1 |c 02 |h 83-87 |
author_variant |
s r sr m r mr l z b lz lzb |
---|---|
matchkey_str |
riegelmansidneyrowlandmalcolmbenetleslie:1973----:dedmuefstpsniaal |
hierarchy_sort_str |
1973 |
publishDate |
1973 |
allfields |
10.1007/BF01060029 doi (DE-627)SPR014694255 (SPR)BF01060029-e DE-627 ger DE-627 rakwb eng Riegelman, Sidney verfasserin aut Addendum 1. Use of isotopes in bioavailability testing 1973 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Dosage Form (dpeaa)DE-He213 Total Radioactivity (dpeaa)DE-He213 Intact Drug (dpeaa)DE-He213 Final Dosage Form (dpeaa)DE-He213 Bioavailability Test (dpeaa)DE-He213 Rowland, Malcolm verfasserin aut Benet, Leslie Z. verfasserin aut Enthalten in Journal of Pharmacokinetics and Biopharmaceutics Kluwer Academic Publishers-Plenum Publishers, 1973 1(1973), 1 vom: Feb., Seite 83-87 (DE-627)SPR014694166 nnns volume:1 year:1973 number:1 month:02 pages:83-87 https://dx.doi.org/10.1007/BF01060029 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_40 AR 1 1973 1 02 83-87 |
spelling |
10.1007/BF01060029 doi (DE-627)SPR014694255 (SPR)BF01060029-e DE-627 ger DE-627 rakwb eng Riegelman, Sidney verfasserin aut Addendum 1. Use of isotopes in bioavailability testing 1973 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Dosage Form (dpeaa)DE-He213 Total Radioactivity (dpeaa)DE-He213 Intact Drug (dpeaa)DE-He213 Final Dosage Form (dpeaa)DE-He213 Bioavailability Test (dpeaa)DE-He213 Rowland, Malcolm verfasserin aut Benet, Leslie Z. verfasserin aut Enthalten in Journal of Pharmacokinetics and Biopharmaceutics Kluwer Academic Publishers-Plenum Publishers, 1973 1(1973), 1 vom: Feb., Seite 83-87 (DE-627)SPR014694166 nnns volume:1 year:1973 number:1 month:02 pages:83-87 https://dx.doi.org/10.1007/BF01060029 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_40 AR 1 1973 1 02 83-87 |
allfields_unstemmed |
10.1007/BF01060029 doi (DE-627)SPR014694255 (SPR)BF01060029-e DE-627 ger DE-627 rakwb eng Riegelman, Sidney verfasserin aut Addendum 1. Use of isotopes in bioavailability testing 1973 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Dosage Form (dpeaa)DE-He213 Total Radioactivity (dpeaa)DE-He213 Intact Drug (dpeaa)DE-He213 Final Dosage Form (dpeaa)DE-He213 Bioavailability Test (dpeaa)DE-He213 Rowland, Malcolm verfasserin aut Benet, Leslie Z. verfasserin aut Enthalten in Journal of Pharmacokinetics and Biopharmaceutics Kluwer Academic Publishers-Plenum Publishers, 1973 1(1973), 1 vom: Feb., Seite 83-87 (DE-627)SPR014694166 nnns volume:1 year:1973 number:1 month:02 pages:83-87 https://dx.doi.org/10.1007/BF01060029 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_40 AR 1 1973 1 02 83-87 |
allfieldsGer |
10.1007/BF01060029 doi (DE-627)SPR014694255 (SPR)BF01060029-e DE-627 ger DE-627 rakwb eng Riegelman, Sidney verfasserin aut Addendum 1. Use of isotopes in bioavailability testing 1973 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Dosage Form (dpeaa)DE-He213 Total Radioactivity (dpeaa)DE-He213 Intact Drug (dpeaa)DE-He213 Final Dosage Form (dpeaa)DE-He213 Bioavailability Test (dpeaa)DE-He213 Rowland, Malcolm verfasserin aut Benet, Leslie Z. verfasserin aut Enthalten in Journal of Pharmacokinetics and Biopharmaceutics Kluwer Academic Publishers-Plenum Publishers, 1973 1(1973), 1 vom: Feb., Seite 83-87 (DE-627)SPR014694166 nnns volume:1 year:1973 number:1 month:02 pages:83-87 https://dx.doi.org/10.1007/BF01060029 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_40 AR 1 1973 1 02 83-87 |
allfieldsSound |
10.1007/BF01060029 doi (DE-627)SPR014694255 (SPR)BF01060029-e DE-627 ger DE-627 rakwb eng Riegelman, Sidney verfasserin aut Addendum 1. Use of isotopes in bioavailability testing 1973 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Dosage Form (dpeaa)DE-He213 Total Radioactivity (dpeaa)DE-He213 Intact Drug (dpeaa)DE-He213 Final Dosage Form (dpeaa)DE-He213 Bioavailability Test (dpeaa)DE-He213 Rowland, Malcolm verfasserin aut Benet, Leslie Z. verfasserin aut Enthalten in Journal of Pharmacokinetics and Biopharmaceutics Kluwer Academic Publishers-Plenum Publishers, 1973 1(1973), 1 vom: Feb., Seite 83-87 (DE-627)SPR014694166 nnns volume:1 year:1973 number:1 month:02 pages:83-87 https://dx.doi.org/10.1007/BF01060029 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_40 AR 1 1973 1 02 83-87 |
language |
English |
source |
Enthalten in Journal of Pharmacokinetics and Biopharmaceutics 1(1973), 1 vom: Feb., Seite 83-87 volume:1 year:1973 number:1 month:02 pages:83-87 |
sourceStr |
Enthalten in Journal of Pharmacokinetics and Biopharmaceutics 1(1973), 1 vom: Feb., Seite 83-87 volume:1 year:1973 number:1 month:02 pages:83-87 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
Dosage Form Total Radioactivity Intact Drug Final Dosage Form Bioavailability Test |
isfreeaccess_bool |
false |
container_title |
Journal of Pharmacokinetics and Biopharmaceutics |
authorswithroles_txt_mv |
Riegelman, Sidney @@aut@@ Rowland, Malcolm @@aut@@ Benet, Leslie Z. @@aut@@ |
publishDateDaySort_date |
1973-02-01T00:00:00Z |
hierarchy_top_id |
SPR014694166 |
id |
SPR014694255 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR014694255</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519072601.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201006s1973 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/BF01060029</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR014694255</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)BF01060029-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Riegelman, Sidney</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Addendum 1. Use of isotopes in bioavailability testing</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1973</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Dosage Form</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Total Radioactivity</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Intact Drug</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Final Dosage Form</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bioavailability Test</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rowland, Malcolm</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Benet, Leslie Z.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Journal of Pharmacokinetics and Biopharmaceutics</subfield><subfield code="d">Kluwer Academic Publishers-Plenum Publishers, 1973</subfield><subfield code="g">1(1973), 1 vom: Feb., Seite 83-87</subfield><subfield code="w">(DE-627)SPR014694166</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1</subfield><subfield code="g">year:1973</subfield><subfield code="g">number:1</subfield><subfield code="g">month:02</subfield><subfield code="g">pages:83-87</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/BF01060029</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1</subfield><subfield code="j">1973</subfield><subfield code="e">1</subfield><subfield code="c">02</subfield><subfield code="h">83-87</subfield></datafield></record></collection>
|
author |
Riegelman, Sidney |
spellingShingle |
Riegelman, Sidney misc Dosage Form misc Total Radioactivity misc Intact Drug misc Final Dosage Form misc Bioavailability Test Addendum 1. Use of isotopes in bioavailability testing |
authorStr |
Riegelman, Sidney |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)SPR014694166 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut aut |
collection |
springer |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
Addendum 1. Use of isotopes in bioavailability testing Dosage Form (dpeaa)DE-He213 Total Radioactivity (dpeaa)DE-He213 Intact Drug (dpeaa)DE-He213 Final Dosage Form (dpeaa)DE-He213 Bioavailability Test (dpeaa)DE-He213 |
topic |
misc Dosage Form misc Total Radioactivity misc Intact Drug misc Final Dosage Form misc Bioavailability Test |
topic_unstemmed |
misc Dosage Form misc Total Radioactivity misc Intact Drug misc Final Dosage Form misc Bioavailability Test |
topic_browse |
misc Dosage Form misc Total Radioactivity misc Intact Drug misc Final Dosage Form misc Bioavailability Test |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Journal of Pharmacokinetics and Biopharmaceutics |
hierarchy_parent_id |
SPR014694166 |
hierarchy_top_title |
Journal of Pharmacokinetics and Biopharmaceutics |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)SPR014694166 |
title |
Addendum 1. Use of isotopes in bioavailability testing |
ctrlnum |
(DE-627)SPR014694255 (SPR)BF01060029-e |
title_full |
Addendum 1. Use of isotopes in bioavailability testing |
author_sort |
Riegelman, Sidney |
journal |
Journal of Pharmacokinetics and Biopharmaceutics |
journalStr |
Journal of Pharmacokinetics and Biopharmaceutics |
lang_code |
eng |
isOA_bool |
false |
recordtype |
marc |
publishDateSort |
1973 |
contenttype_str_mv |
txt |
container_start_page |
83 |
author_browse |
Riegelman, Sidney Rowland, Malcolm Benet, Leslie Z. |
container_volume |
1 |
format_se |
Elektronische Aufsätze |
author-letter |
Riegelman, Sidney |
doi_str_mv |
10.1007/BF01060029 |
author2-role |
verfasserin |
title_sort |
addendum 1. use of isotopes in bioavailability testing |
title_auth |
Addendum 1. Use of isotopes in bioavailability testing |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_40 |
container_issue |
1 |
title_short |
Addendum 1. Use of isotopes in bioavailability testing |
url |
https://dx.doi.org/10.1007/BF01060029 |
remote_bool |
true |
author2 |
Rowland, Malcolm Benet, Leslie Z. |
author2Str |
Rowland, Malcolm Benet, Leslie Z. |
ppnlink |
SPR014694166 |
mediatype_str_mv |
c |
isOA_txt |
false |
hochschulschrift_bool |
false |
doi_str |
10.1007/BF01060029 |
up_date |
2024-07-04T02:44:41.978Z |
_version_ |
1803614769098260480 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR014694255</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519072601.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201006s1973 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/BF01060029</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR014694255</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)BF01060029-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Riegelman, Sidney</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Addendum 1. Use of isotopes in bioavailability testing</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1973</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Dosage Form</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Total Radioactivity</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Intact Drug</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Final Dosage Form</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bioavailability Test</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rowland, Malcolm</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Benet, Leslie Z.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Journal of Pharmacokinetics and Biopharmaceutics</subfield><subfield code="d">Kluwer Academic Publishers-Plenum Publishers, 1973</subfield><subfield code="g">1(1973), 1 vom: Feb., Seite 83-87</subfield><subfield code="w">(DE-627)SPR014694166</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1</subfield><subfield code="g">year:1973</subfield><subfield code="g">number:1</subfield><subfield code="g">month:02</subfield><subfield code="g">pages:83-87</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/BF01060029</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1</subfield><subfield code="j">1973</subfield><subfield code="e">1</subfield><subfield code="c">02</subfield><subfield code="h">83-87</subfield></datafield></record></collection>
|
score |
7.4004107 |